Related references
Note: Only part of the references are listed.Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
H. Tinto et al.
LANCET (2015)
Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naive Adults
Christian F. Ockenhouse et al.
PLOS ONE (2015)
High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination
Yann-Chong Tan et al.
CLINICAL IMMUNOLOGY (2014)
Dosing Schedules for Pneumococcal Conjugate Vaccine Considerations for Policy Makers
Cynthia G. Whitney et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
Priming after a Fractional Dose of Inactivated Poliovirus Vaccine
Sonia Resik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Relationship between RTS,S Vaccine-Induced Antibodies, CD4+ T Cell Responses and Protection against Plasmodium falciparum Infection
Michael T. White et al.
PLOS ONE (2013)
Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV)
Claudius Malerczyk et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Germinal center selection and the development of memory B and plasma cells
Mark J. Shlomchik et al.
IMMUNOLOGICAL REVIEWS (2012)
Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum
Frederic Clement et al.
MALARIA JOURNAL (2012)
Development of a Highly Sensitive Genus-Specific Quantitative Reverse Transcriptase Real-Time PCR Assay for Detection and Quantitation of Plasmodium by Amplifying RNA and DNA of the 18S rRNA Genes
Edwin Kamau et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial
Kwaku Poku Asante et al.
LANCET INFECTIOUS DISEASES (2011)
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
Selidji Todagbe Agnandji et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
From the circumsporozoite protein to the RTS, S/AS candidate vaccine
Joe Cohen et al.
HUMAN VACCINES (2010)
Impact of national malaria control scale-up programmes in Africa: magnitude and attribution of effects
Richard W. Steketee et al.
MALARIA JOURNAL (2010)
Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naive adults at the Walter Reed Army Institute of Research
Kent E. Kester et al.
VACCINE (2008)
Immunogenicity of Fractional Doses of Tetravalent A/C/Y/W135 Meningococcal Polysaccharide Vaccine: Results from a Randomized Non-Inferiority Controlled Trial in Uganda
Philippe J. Guerin et al.
PLOS NEGLECTED TROPICAL DISEASES (2008)
Sense and the science of childhood immunization: Can we achieve more with less?
Stephen K. Obaro et al.
VACCINE (2006)
SoDA: implementation of a 3D alignment algorithm for inference of antigen receptor recombinations
JM Volpe et al.
BIOINFORMATICS (2006)
Can successful vaccines teach us how to induce efficient protective immune responses?
PH Lambert et al.
NATURE MEDICINE (2005)
Accelerated hepatitis B vaccination schedule in childhood
M Bosnak et al.
PEDIATRICS INTERNATIONAL (2002)
Share Paper
